Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123850052 | 12385005 | 2 | F | 201506 | 20160620 | 20160519 | 20160701 | EXP | US-ACORDA-ACO_122794_2016 | ACORDA | 70.03 | YR | M | Y | 86.62000 | KG | 20160701 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123850052 | 12385005 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | Y | SDYT | 22250 | 10 | MG | TABLET | BID | ||||
| 123850052 | 12385005 | 2 | C | DITROPAN | OXYBUTYNIN CHLORIDE | 1 | Oral | 5 MG, TID | U | 0 | 5 | MG | TABLET | TID | |||||
| 123850052 | 12385005 | 3 | C | Atorvastatin | ATORVASTATIN | 1 | Oral | 10 MG, HS | U | 0 | 10 | MG | TABLET | QD | |||||
| 123850052 | 12385005 | 4 | C | FLUTICASONE | FLUTICASONEFLUTICASONE PROPIONATE | 1 | Nasal | 1 SPRAY (50 MCG/INH), QD | U | 0 | NASAL SPRAY | QD | |||||||
| 123850052 | 12385005 | 5 | C | LASIX | FUROSEMIDE | 1 | Oral | 40 MG, QD | U | 0 | 40 | MG | TABLET | QD | |||||
| 123850052 | 12385005 | 6 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Oral | 400 MG, BID | U | 0 | 400 | MG | TABLET | BID | |||||
| 123850052 | 12385005 | 7 | C | Pantoprazole | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, BID | U | 0 | 40 | MG | TABLET | BID | |||||
| 123850052 | 12385005 | 8 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Oral | 20 MEQ, BID WITH FOOD | U | 0 | 20 | MEQ | TABLET | BID | |||||
| 123850052 | 12385005 | 9 | C | SUCRALFATE. | SUCRALFATE | 1 | Oral | 1 G, QID BEFORE MEALS AND AT BEDTIME | U | 0 | 1 | G | TABLET | QID | |||||
| 123850052 | 12385005 | 10 | C | Tamsulosin | TAMSULOSIN | 1 | Oral | 0.8 MG, HS | U | 0 | .8 | MG | CAPSULE | QD | |||||
| 123850052 | 12385005 | 11 | C | Warfarin | WARFARIN | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | TABLET | QD | |||||
| 123850052 | 12385005 | 12 | C | BACLOFEN. | BACLOFEN | 1 | Oral | 10-20 MG, HS | U | 0 | TABLET | QD | |||||||
| 123850052 | 12385005 | 13 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Unknown | UNK | U | 0 | |||||||||
| 123850052 | 12385005 | 14 | C | BETASERON | INTERFERON BETA-1B | 1 | Subcutaneous | 0.3 MG, QOD | U | 0 | .3 | MG | QOD | ||||||
| 123850052 | 12385005 | 15 | C | CLARITIN | LORATADINE | 1 | Unknown | 10 MG, UNK | U | 0 | 10 | MG | |||||||
| 123850052 | 12385005 | 16 | C | Multivitamin | VITAMINS | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | TABLET | QD | |||||
| 123850052 | 12385005 | 17 | C | NITROSTAT | NITROGLYCERIN | 1 | Sublingual | 0.4 MG, EVERY 5 MINUTES PRN | U | 0 | .4 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123850052 | 12385005 | 1 | Gait disturbance |
| 123850052 | 12385005 | 2 | Product used for unknown indication |
| 123850052 | 12385005 | 3 | Product used for unknown indication |
| 123850052 | 12385005 | 4 | Product used for unknown indication |
| 123850052 | 12385005 | 5 | Product used for unknown indication |
| 123850052 | 12385005 | 6 | Product used for unknown indication |
| 123850052 | 12385005 | 7 | Product used for unknown indication |
| 123850052 | 12385005 | 8 | Product used for unknown indication |
| 123850052 | 12385005 | 9 | Product used for unknown indication |
| 123850052 | 12385005 | 10 | Product used for unknown indication |
| 123850052 | 12385005 | 11 | Product used for unknown indication |
| 123850052 | 12385005 | 12 | Muscle spasms |
| 123850052 | 12385005 | 13 | Product used for unknown indication |
| 123850052 | 12385005 | 14 | Product used for unknown indication |
| 123850052 | 12385005 | 15 | Product used for unknown indication |
| 123850052 | 12385005 | 16 | Product used for unknown indication |
| 123850052 | 12385005 | 17 | Chest pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123850052 | 12385005 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123850052 | 12385005 | Acute respiratory failure | |
| 123850052 | 12385005 | Arteriosclerosis coronary artery | |
| 123850052 | 12385005 | Asthenia | |
| 123850052 | 12385005 | Atrial fibrillation | |
| 123850052 | 12385005 | Cardiac failure | |
| 123850052 | 12385005 | Cervical myelopathy | |
| 123850052 | 12385005 | Conduction disorder | |
| 123850052 | 12385005 | Device leakage | |
| 123850052 | 12385005 | Drug ineffective | |
| 123850052 | 12385005 | Hyperlipidaemia | |
| 123850052 | 12385005 | Hypertension | |
| 123850052 | 12385005 | Movement disorder | |
| 123850052 | 12385005 | Multiple sclerosis relapse | |
| 123850052 | 12385005 | Musculoskeletal pain | |
| 123850052 | 12385005 | Orthostatic hypotension | |
| 123850052 | 12385005 | Pulmonary embolism | |
| 123850052 | 12385005 | Restless legs syndrome | |
| 123850052 | 12385005 | Sciatica | |
| 123850052 | 12385005 | Sleep apnoea syndrome | |
| 123850052 | 12385005 | Type 2 diabetes mellitus | |
| 123850052 | 12385005 | Umbilical hernia | |
| 123850052 | 12385005 | Urinary retention |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123850052 | 12385005 | 1 | 201506 | 201506 | 0 |